Capstead Mortgage Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMO research report →
Price Chart
About the company
Capstead Mortgage Corporation functions as an American real estate investment trust (REIT), focusing its operations on a diverse portfolio of residential mortgage pass-through securities. Its primary investment strategy centers on acquiring short-duration adjustable-rate mortgage (ARM) securities, specifically those issued and guaranteed by government-sponsored enterprises or agencies of the federal government. Holding the designation of a qualified REIT for federal income tax purposes, the company typically benefits from an exemption from federal corporate income taxes, provided it distributes a minimum of 90% of its taxable profits to its shareholders.
- CEO
- Phillip Reinsch
- IPO
- 1985
- Employees
- 15
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on CMO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $0
- P/E
- -4062.50
- PEG
- -24.48
- P/S
- 0.00
- P/B
- -957.80
- EV/EBITDA
- -49780.66
- Div Yield
- 8.03%
- Gross Margin
- 100.00%
- Op Margin
- -10664.62%
- Net Margin
- 326.29%
- ROE
- 27.26%
- ROIC
- -30.12%
Latest fiscal year · YoY change
- Revenue
- $-45,665-103.0%
- Gross Profit
- $-45,665-103.0%
- Op Income
- $4.87M
- Net Income
- $-149,000-171.9%
- EPS
- $-0.00+99.7%
- OCF Growth
- +2.1%
- FCF Growth
- -100.0%
- 52W High
- $7.00
- 52W Low
- $5.06
- 50D MA
- $6.83
- 200D MA
- $6.53
- Beta
- 1.54
- RSI (14)
- 37
- Avg Volume
- 859.28K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Capstead’s first quarter was solid on GAAP earnings, but core earnings slipped below the dividend after higher premium amortization and a smaller portfolio reduced earnings power.· April 29, 2021
- GAAP net income was $18.9 million, or $0.15 per diluted share; core earnings were $17.4 million, or $0.13 per diluted share.
- Book value fell $0.10 per share to $6.66, with $0.17 of derivative-related gains offset by $0.22 of portfolio-related declines and $0.05 from capital activity.
- Portfolio yields averaged 1.38%, down 17 basis points from 1.55% last quarter, mainly due to $2.3 million of additional premium amortization and lower reset rates.
- The company bought about $400 million in the quarter versus almost $900 million of runoff, and management said it is already ahead of that pace in early Q2.
- Management sees better opportunities as ARM supply improves, but expects the duration gap to stay near three months and hedges to be kept roughly constant.
GAAP net income was $18.9 million, or $0.15 per diluted common share. Core earnings were $17.4 million, or $0.13 per diluted common share, versus the $0.15 quarterly dividend referenced by management. Book value ended at $6.66 per common share, down $0.10, or 1.4%, from the prior quarter. Portfolio yields averaged 1.38%, down 17 basis points from 1.55% in the prior quarter, and management said $2.3 million of additional premium amortization cut yield by about 12 basis points. The average portfolio balance was down approximately $500 million from the previous quarter, and the company bought about $400 million in the first quarter versus almost $900 million of runoff. Looking ahead, management said it is already well ahead of the first-quarter purchase pace, but did not quantify second-quarter purchases or give explicit EPS guidance.
Phil Reinsch said Capstead has continued to cover its dividend through the pandemic until this quarter, but that higher prepayment speeds and a smaller portfolio pressured results. He emphasized that prepayment rates are likely cresting and should fall as mortgage rates have risen and refinancing activity cools. Strategically, he said the company is finding better reinvestment opportunities as ARM supply picks up, while staying mindful of longer duration risk in newer issue paper.
Lance Phillips walked through the quarter’s reported numbers and the drivers behind the decline in earnings power. He said GAAP net income was $18.9 million and core earnings were $17.4 million, with the quarter affected by $2.3 million of additional premium amortization tied to revised lifetime prepayment speed assumptions. He also noted book value of $6.66 per share, down $0.10, and said the average portfolio balance fell by about $500 million because the company did not fully replace runoff.
Analysts focused on why core earnings dropped to $0.13 and whether the shortfall versus the dividend was temporary. Management said the $0.02 decline was directly attributable to the $2.3 million of additional amortization, though a smaller portfolio also hurt earnings, and Phil described the speed adjustment as a one-off-type event rather than something that happens often. Questions also centered on whether the company would grow the portfolio and how hedges would change; management said the duration gap is a little over three months now, should stay fairly flat, and that hedging will be adjusted as newer, longer-duration paper is added.
The company sees a more favorable backdrop developing as the yield curve steepens and new issue ARM supply rebounds sharply. Management said April new issue agency ARM sales topped $1.25 billion, originators are pushing ARMs more actively, and there is more paper available in later-settlement months at better relative value. They also expect prepayment rates to fall in coming months as mortgage rates rise.
Core earnings of $0.13 per share no longer covered the $0.15 dividend in the quarter, after a $2.3 million amortization adjustment and a smaller portfolio reduced earnings power. Book value declined and the company did not fully replace runoff, leaving the average portfolio balance about $500 million lower than the prior quarter. Management also said front-month new issue paper remains rich and that portfolio growth will depend on finding attractive reinvestment opportunities.
AI summary of the company's earnings call · Paraphrased · Not investment advice
of shares held by institutions
144 13F filers
Congressional trading
Senate and House stock disclosures for CMO, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Aperio Group, LLC | 33.15K | ▼ 1.17K |
| Pictet Asset Management Ltd | 10.50K | 0 |
| Berman Capital Advisors, LLC | 4.63K | ▲ 1.90K |
Held by 3 ETFs
Biggest fund positions in CMO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 19, 21 | Kim Roy | other | 144,305 |
| Oct 19, 21 | Kim Roy | sell | 391,644 |
| Oct 19, 21 | Kim Roy | other | 144,305 |
| Oct 19, 21 | REINSCH PHILLIP A | other | 211,359 |
| Oct 19, 21 | REINSCH PHILLIP A | other | 211,359 |
| Oct 19, 21 | REINSCH PHILLIP A | sell | 743,593 |
| Oct 19, 21 | REINSCH PHILLIP A | sell | 3,500 |
| Oct 19, 21 | Phillips Lance | other | 107,232 |
| Oct 19, 21 | Phillips Lance | sell | 252,633 |
| Oct 19, 21 | Phillips Lance | other | 107,232 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CMO coverage
Recent articles, reports, and earnings notes.
No research on CMO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMO report →Target Corp (TGT) (Q2 2026) Earnings Call Highlights: Comparable Sales Surge 3.8% and Full-Year Guidance Raised
gurufocus.com · Aug 19
Kimball Electronics, Inc. Announces Date For Reporting Fourth Quarter and Fiscal Year 2026 Financial Results
gurufocus.com · Jul 29
Metrie Announces Several Executive Leadership Team Promotions
businesswire.com · Feb 5
Boeing Forecasts Demand for 42,600 New Commercial Jets Over Next 20 Years
headlinesoftoday.com · Jun 17
EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer
headlinesoftoday.com · Jun 7
Chargebee appoints Guy Marion as Chief Marketing Officer
headlinesoftoday.com · May 4
Mixbook Appoints New CMO, Benjamin De Castro, Rounding Out its First-Class Executive Leadership Team
businesswire.com · Jan 16
Suzanne Behrens Joins Granicus as Chief Marketing Officer
headlinesoftoday.com · Jul 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.